Association between neuropathology and brain volume in the framingham heart study

Alzheimer Disease and Associated Disorders

Volumn 28, Issue 3, 2014, Pages 219-225

  Kaur, Berneet ^a   Himali, Jayandra J ^b   Seshadri, Sudha ^b   Beiser, Alexa S ^b,c   Au, Rhoda ^b   McKee, Ann C ^b   Auerbach, Sanford ^b   Wolf, Philip A ^b   Decarli, Charles S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Alzheimer disease; cerebrovascular disease; dementia; MRI; neuropathology

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; BLOOD VESSEL INJURY; BRAIN INFARCTION SIZE; BRAIN SIZE; BRAIN WEIGHT; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COHORT ANALYSIS; CORRELATIONAL STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; GENOTYPE; HIPPOCAMPAL SCLEROSIS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENILE PLAQUE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR AMYLOIDOSIS; BRAIN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; BRAIN; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE;

EID: 84907140941     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000032     Document Type: Article

References (37)

1. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119-128.
2. Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002;58:750-757.
3. Csernansky JG, Hamstra J, Wang L, et al. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Dis. 2004; 18:190-195.
4. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology. Neurology. 2002;58:1476-1482.
5. Schneider JA, Arvanitakis Z, Bang W, et al. Mixed brain pathologies account for most dementia cases in communitydwelling older persons. Neurology. 2007;69:2197-2204.
6. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008;63:72-80.
7. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke. 2004;35:1857-1861.
8. Massaro JM, D'Agostino RB Sr, Sullivan LM, et al. Managing and analysing data from a large-scale study on Framingham offspring relating brain structure to cognitive function. Stat Med. 2004;23:351-367.
9. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study. Neurology. 2004;63:1591-1599.
10. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the framingham heart study: Establishing what is normal. Neurobiol Aging. 2005;26: 491-510.
11. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health Nations Health. 1951;41:279-281.
12. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 1992;42:115-119.
13. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology. 1993;43:515-519.
14. Beiser A, D'Agostino RB Sr, Seshadri S, et al. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495-1522.
15. Au R, Seshadri S, Knox K, et al. The Framingham Brain Donation Program: Neuropathology along the cognitive continuum. Curr Alzheimer Res. 2012;9:673-686.
16. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: Author; 2000.
17. Morris JC. The clinical dementia rating (CDR): Current version and scoring rules. Neurology. 1993;43:2412-2414.
18. DeCarli C, Maisog J, Murphy DG, et al. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr. 1992;16: 274-284.
19. DeCarli C, Miller BL, Swan GE, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke. 1999;30:529-536.
20. Seshadri S, Wolf PA, Beiser AS, et al. Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008;65:642-649.
21. DeCarli C, Murphy DG, Teichberg D, et al. Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity. J Magn Reson Imaging. 1996;6:519-528.
22. DeCarli C, Murphy D, Gillette J, et al. Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol. 1994;15:689-696.
23. Murphy DG, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: An in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry. 1996;53:585-594.
24. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol. 1991;82:239-259.
25. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
26. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241.
27. Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42: 631-639.
28. Silbert LC, Quinn JF, MooreMM, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 2003;61:487-492.
29. Hedden T, Oh H, Younger AP, et al. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80:1341-1348.
30. Rabinovici GD, Jagust WJ. Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo. Behav Neurol. 2009;21:117-128.
31. Jack CR, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008;131:665-680.
32. Marchant NL, Reed BR, Sanossian N, et al. The aging brain and cognition: Contribution of vascular injury and ab to mild cognitive dysfunction. JAMA Neurology. 2013;70:488-495.
33. Albert M, Massaro J, DeCarli C, et al. Profiles by sex of brain MRI and cognitive function in the framingham offspring study. Alzheimer Dis Assoc Disord. 2010;24:190-193.
34. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: The Framingham Heart Study. Arch Neurol. 2006;63:246-250.
35. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol. 1993;34:566-573.
36. Corrada MM, Berlau DJ, Kawas CH. A population-based clinicopathological study in the oldest-old: The 90+ study. Curr Alzheimer Res. 2012;9:709-717.
37. Cairns NJ, Taylor-Reinwald L, Morris JC. Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the neuropathology core. Alzheimer Dement. 2010;6:274-279.